BeStock  
Stocks › Biotechnology › VKTX

Viking Therapeutics VKTX

US equityMarket cap rank #2332Biotechnology
$29.28 −$0.66 (-2.20%)
Pre-market · Oct 6, 4:20 am ET · After hours $29.33 +0.17%
Open$30.14
Prev close$29.94
Day range$28.71 – $30.18
Volume6.28M
Market cap$3.68B
P/E (TTM)–
Dividend yield–

VKTX Stock News

Headlines matching Viking Therapeutics or the VKTX ticker, most recent first.

  • B. Riley Securities Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $85Market news · 9 Sep 2026
  • A Quick Look at Today's Ratings for Viking Therapeutics(VKTX.US), With a Forecast Between $70 to $114Market news · 24 Sep 2026
  • A Quick Look at Today's Ratings for Viking Therapeutics(VKTX.US), With a Forecast Between $87 to $125Market news · 23 Sep 2026
  • Analysts Offer Insights on Healthcare Companies: Maze Therapeutics, Inc. (MAZE), Viking Therapeutics (VKTX) and Aytu BioScience (AYTU)TipRanks · 23 Sep 2026
  • Analysts Are Bullish on Top Healthcare Stocks: Maze Therapeutics, Inc. (MAZE), Viking Therapeutics (VKTX)TipRanks · 23 Sep 2026
  • Oppenheimer Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $100Market news · 3 Aug 2026
  • Cantor Fitzgerald Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $100Market news · 14 Aug 2026
  • J.P. Morgan Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Cuts Target Price to $65Market news · 11 Aug 2026
  • Maxim Group Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $70Market news · 1 Aug 2026
  • Piper Sandler Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $71Market news · 7 Jul 2026
  • Jefferies Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $101Market news · 30 Jul 2026
  • A Quick Look at Today's Ratings for Viking Therapeutics(VKTX.US), With a Forecast Between $71 to $114Market news · 30 Jul 2026
  • Morgan Stanley Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $95Market news · 30 Jul 2026
  • Stifel Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $95Market news · 30 Jul 2026
  • CCORF Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $107Market news · 15 Jul 2026

Discussion

No comments yet — be the first to weigh in on VKTX.

Leave a comment

Scroll to Top